27 Matching Annotations
  1. Last 7 days
  2. www.biorxiv.org www.biorxiv.org
    Ascites-Driven Modulation of Cell Phenotypes and Proteomes: Implications for Cancer Progression
    2
    Visit annotations in context

    Tags

    Annotators

    URL

    biorxiv.org/content/10.64898/2026.02.12.705674v1
  3. Sep 2025
  4. www.sciencedirect.com www.sciencedirect.com
    Epigenetic modulation of BARD1 to enhance anti-VEGF therapy
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2666379125004021
  5. Jun 2025
  6. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    1-s2.0-S2589004225008168-main-html.html
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC12145850/
  7. May 2025
  8. febs.onlinelibrary.wiley.com febs.onlinelibrary.wiley.com
    FEBS Press
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    febs.onlinelibrary.wiley.com/doi/full/10.1002/1878-0261.70051
  9. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    1-s2.0-S2589004225008168-main-html.html
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC12145850/
  10. Feb 2025
  11. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    PARP Inhibitors Differentially Regulate Immune Responses in Distinct Genetic Backgrounds of High-Grade Serous Tubo-Ovarian Carcinoma
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC11836641/
  12. Jan 2025
  13. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Cyclin E1/CDK2 activation defines a key vulnerability to WEE1 kinase inhibition in gynecological cancers
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC11700143/
  14. Dec 2024
  15. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Pan-Cancer Analysis of Homologous Recombination Deficiency in Cell Lines
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC11621922/
  16. Jul 2024
  17. ovarianresearch.biomedcentral.com ovarianresearch.biomedcentral.com
    Unveiling G-protein coupled receptors as potential targets for ovarian cancer nanomedicines: from RNA sequencing data analysis to in vitro validation
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ovarianresearch.biomedcentral.com/articles/10.1186/s13048-024-01479-0
  18. May 2024
  19. aacrjournals.org aacrjournals.org
    TREX1 inactivation unleashes cancer cell STING-interferon signaling and promotes anti-tumor immunity
    2
    Visit annotations in context

    Tags

    Annotators

    URL

    aacrjournals.org/cancerdiscovery/article/14/5/752/745044/TREX1-Inactivation-Unleashes-Cancer-Cell-STING
  20. Dec 2023
  21. www.sciencedirect.com www.sciencedirect.com
    PRMT blockade induces defective DNA replication stress response and synergizes with PARP inhibition
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2666379123005438
  22. Apr 2023
  23. aacrjournals.org aacrjournals.org
    N6-Methyladenosine RNA Modifications Regulate the Response to Platinum through Nicotinamide N-methyltransferase
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    aacrjournals.org/mct/article/22/3/393/718396/N6-Methyladenosine-RNA-Modifications-Regulate-the
  24. Mar 2023
  25. academic.oup.com academic.oup.com
    Excessive transcription-replication conflicts are a vulnerability of BRCA1-mutant cancers
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    academic.oup.com/nar/advance-article/doi/10.1093/nar/gkad172/7079642
  26. Feb 2023
  27. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    KDM5A Inhibits Antitumor Immune Responses Through Downregulation of the Antigen-Presentation Pathway in Ovarian Cancer
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC9357105/
  28. Jul 2022
  29. 52.53.155.43 52.53.155.43
    cir-22-0088-html.html
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    52.53.155.43/a65b09b78e7767f723c9ad153c89aec9ed13d4e6/cir-22-0088-html.html
  30. Jun 2022
  31. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    The SETDB1–TRIM28 complex suppresses antitumor immunity
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC8647838/
  32. Apr 2022
  33. aacrjournals.org aacrjournals.org
    Rational Combination of CRM1 Inhibitor Selinexor and Olaparib Shows Synergy in Ovarian Cancer Cell Lines and Mouse Models
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    aacrjournals.org/mct/article/20/12/2352/675163/Rational-Combination-of-CRM1-Inhibitor-Selinexor
  34. Feb 2022
  35. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Phenethyl Isothiocyanate Enhances the Cytotoxic Effects of PARP Inhibitors in High-Grade Serous Ovarian Cancer Cells
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC8825372/
  36. Aug 2021
  37. www.sciencedirect.com www.sciencedirect.com
    Cytotoxic capacity of a novel glycosylated antitumor ether lipid in chemotherapy-resistant high grade serous ovarian cancer in vitro and in vivo
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S1936523321001959
  38. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Untitled document
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC6251623/
  39. Jul 2021
  40. www.sciencedirect.com www.sciencedirect.com
    MYC status as a determinant of synergistic response to Olaparib and Palbociclib in ovarian cancer
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2352396419301677
  41. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    The oncogenic Golgi phosphoprotein 3 like overexpression is associated with cisplatin resistance in ovarian carcinoma and activating the NF-κB signaling pathway
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC5628490/
  42. Oct 2020
  43. mcr.aacrjournals.org mcr.aacrjournals.org
    Mitochondria participate in chemoresistance to cisplatin in human ovarian cancer cells
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    mcr.aacrjournals.org/content/18/9/1379
  44. Sep 2020
  45. onlinelibrary.wiley.com onlinelibrary.wiley.com
    Novel Ovarian Cancer Maintenance Therapy Targeted at Mortalin and Mutant p53
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    onlinelibrary.wiley.com/doi/10.1002/ijc.32830
  46. Nov 2017
  47. www.sciencedirect.com www.sciencedirect.com
    Lipid Desaturation Is a Metabolic Marker and Therapeutic Target of Ovarian Cancer Stem Cells
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S1934590916304003